Finance

Lists
Why is ANTX down 5,42%?
Dive Deeper
ANTX:NASDAQ
AN2 Therapeutics Inc
4,80 US$
-5,42%
(-0,28) 1D
7 ოქტ, 12:44:26 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANTX...
Open
5,02 US$
High
5,06 US$
Low
4,80 US$
Mkt. cap
180,95 მლნ.
Avg. vol.
254,98 ათ.
Volume
104,08 ათ.
52-wk high
7,19 US$
52-wk low
1,00 US$
EPS
-1,07 US$
Beta
-0,98
Shares outstanding
37,74 მლნ.
No. of employees
21
Open
5,02 US$
High
5,06 US$
Low
4,80 US$
Mkt. cap
180,95 მლნ.
Avg. vol.
254,98 ათ.
Volume
104,08 ათ.
52-wk high
7,19 US$
52-wk low
1,00 US$
EPS
-1,07 US$
Beta
-0,98
Shares outstanding
37,74 მლნ.
No. of employees
21
News stories
From web sources and news partners
About AN2 Therapeutics Inc
CEO-
Employees21
Founded2017
HeadquartersMenlo Park, კალიფორნია, ამერიკის შეერთებული შტატები
SectorPharmaceutical industry
Analyst ratings
Based on 1 analyst giving stock ratings to ANTX in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for ANTX in the last 3 months
Highest
Current 4,80 US$
9,00 US$ (+87,70%)
Average
9,00 US$ (+87,70%)
Lowest
9,00 US$ (+87,70%)
Analyst
Recommendation
Action
Price target
Projected
Date
Bradley Canino
Guggenheim
Buy
Initiated
9,00 US$
+87,7%
07/19/2026
Joseph Schwartz
Leerink Partners
Buy
Upgraded
9,00 US$
+87,7%
05/15/2026
Last report
11 აგვ. 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-0,18 US$ / -0,24 US$
+25,00%beat
Revenue / Est. (USD)
- / 0,00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
7,00 მლნ.
6,88 მლნ.
6,74 მლნ.
6,02 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,04 მლნ.
2,44 მლნ.
3,81 მლნ.
2,88 მლნ.
Operating expense
10,04 მლნ.
9,32 მლნ.
10,55 მლნ.
8,90 მლნ.
Total operating expenses
10,04 მლნ.
9,32 მლნ.
10,55 მლნ.
8,90 მლნ.
Operating income
-10,04 მლნ.
-9,32 მლნ.
-10,55 მლნ.
-8,90 მლნ.
Other non operating income
-
1,00 ათ.
-
-1,00 ათ.
EBT including unusual items
-9,35 მლნ.
-8,71 მლნ.
-10,03 მლნ.
-8,18 მლნ.
EBT excluding unusual items
-9,35 მლნ.
-8,71 მლნ.
-10,03 მლნ.
-8,18 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9,35 მლნ.
-8,71 მლნ.
-10,03 მლნ.
-8,18 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-0,31
-0,29
-0,29
-0,18
Interest and investment income
687,00 ათ.
605,00 ათ.
523,00 ათ.
720,00 ათ.
Interest expense
-
-
-
-
Net interest expenses
687,00 ათ.
605,00 ათ.
523,00 ათ.
720,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები